This Week in Cancer Cell

Premium

In Cancer Cell this week, a team of US researchers reports a study of tumor growth potential in mouse models of glioma. High expression of Id1 in glioma identifies tumor cells with a high capacity for self-renewal, and while low expression of Id1 identifies tumor cells with limited capacity for self-renewal, such cells also have potential for proliferation. "Surprisingly, Id1low cells generate tumors more rapidly and with higher penetrance than Id1high cells," the authors write.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.